BSE Live
Jan 23, 16:01Prev. Close
4055.60
Open Price
4055.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:55Prev. Close
4055.30
Open Price
4055.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 09 | Dec 08 | Dec 07 | Dec 06 | Dec 05 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
| Total Share Capital | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
| Reserves and Surplus | 895.14 | 791.61 | 668.52 | 569.04 | 483.78 | |
| Total Reserves and Surplus | 908.76 | 806.07 | 683.82 | 585.18 | 500.75 | |
| Total Shareholders Funds | 931.79 | 829.10 | 706.85 | 608.21 | 523.78 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 15.23 | 12.89 | 13.99 | 14.04 | 15.71 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 15.23 | 12.89 | 13.99 | 14.04 | 15.71 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 118.22 | 127.23 | 97.34 | 82.31 | 56.34 | |
| Other Current Liabilities | 39.95 | 11.21 | 16.01 | 28.11 | 28.22 | |
| Short Term Provisions | 115.37 | 97.79 | 95.35 | 139.59 | 86.41 | |
| Total Current Liabilities | 273.54 | 236.23 | 208.70 | 250.01 | 170.97 | |
| Total Capital And Liabilities | 1,220.57 | 1,078.23 | 929.55 | 872.26 | 710.46 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 116.83 | 115.36 | 108.20 | 105.27 | 113.74 | |
| Intangible Assets | 28.06 | 27.47 | 27.47 | 27.16 | 26.76 | |
| Capital Work-In-Progress | 27.14 | 6.25 | 9.32 | 13.20 | 1.34 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 172.04 | 149.08 | 144.99 | 145.62 | 141.84 | |
| Non-Current Investments | 5.19 | 5.19 | 5.31 | 5.31 | 5.31 | |
| Deferred Tax Assets [Net] | 29.80 | 28.21 | 26.61 | 27.15 | 21.43 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 207.03 | 182.48 | 176.91 | 178.08 | 168.59 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 231.14 | 172.55 | 180.80 | 158.80 | 136.34 | |
| Trade Receivables | 52.74 | 89.50 | 57.51 | 68.49 | 51.03 | |
| Cash And Cash Equivalents | 585.95 | 497.37 | 390.62 | 386.12 | 294.39 | |
| Short Term Loans And Advances | 143.72 | 136.32 | 123.73 | 80.78 | 60.12 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 1,013.54 | 895.75 | 752.64 | 694.18 | 541.88 | |
| Total Assets | 1,220.57 | 1,078.23 | 929.55 | 872.26 | 710.46 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 157.67 | 150.63 | 132.54 | 132.88 | 117.07 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 346.98 | 244.08 | 219.08 | 218.19 | 210.55 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 4.92 | 2.13 | 1.49 | 1.26 | 0.92 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 5.00 | 6.95 | 5.30 | 3.45 | 4.52 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 18.47 | 18.47 | 36.94 | 18.46 | 18.46 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 224.80 | 205.49 | 166.76 | 220.82 | 222.20 | |
| Other Earnings | 52.17 | 23.60 | 17.80 | 15.12 | 20.34 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 8.76 | 3.67 | 23.37 | 9.37 | 5.10 | |
| Non-Current Investments Unquoted Book Value | 5.06 | 5.06 | 5.18 | 5.18 | 5.18 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y